Accelerate Bio Podcast

Human Gene Editing Has Begun | George Church

We are already gene editing humans. You just haven’t noticed.George Church, Harvard geneticist and Human Genome Project pioneer, explains why CRISPR wasn’t the real breakthrough, how multiplex gene editing unlocked organ transplants and de-extinction, and why aging will likely require rewriting many genes at once.Hosted by Mgoes → https://x.com/m_goes_distanceBrought to you by SuperHuman Fund → https://superhuman.fund/---0:00 - Gene Editing Mammals → Humans8:36 - Germline vs Somatic14:56 - Modified Humans Are Already Here18:50 - Enhancing Healthy Humans25:00 - Aging Therapies vs Cognitive Enhancement30:20 - Embryo Selection38:10 - Is US Losing To UAE?42:33 - Biotech Failures49:31 - Next Dire Wolf Moment54:21 - AI x Science1:02:07 - Synthetizing Entire Genomes---The Accelerate Bio Podcast explores the future of humanity in the age of Artificial Intelligence. Subscribe for deep-dive conversations with founders, scientists, and investors shaping AI, biotechnology, and human progress.---This episode discusses George Church, gene editing, CRISPR, human enhancement, longevity, aging, embryo selection, synthetic biology, multiplex editing, AI biotech.

GLP-1: First Human Enhancement Drug? | Dr. Anant Vinjamoori

GLP-1s may be the first real human enhancement drug.Dr. Anant Vinjamoori - longevity physician and healthtech entrepreneur - explains why GLP-1s matter far beyond weight loss, why they may be the first drug class seriously crossing into longevity medicine, and why they could be a wedge into next-gen peptides, programable biology, and AI-driven human upgrades.Hosted by Mgoes → https://x.com/m_goes_distanceBrought to you by SuperHuman Fund → https://superhuman.fund/---0:00 - Health → Human Enhancement?5:37 - GLP-1s: The Real Novelty8:23 - Next Gen Drugs, Peptides13:29 - Un*ucking Regulation22:50 - Health Influencers & Hype29:23 - Social Media vs AI Discovery35:46 - GLP1s = Prozac?41:35 - Biotech Is The Answer48:19 - AI Drug Discovery---The Accelerate Bio Podcast explores the future of humanity in the age of Artificial Intelligence. Subscribe for deep-dive conversations with founders, scientists, and investors shaping AI, biotechnology, and human progress.---This episode discusses GLP-1s, GLP-1 drugs, semaglutide, tirzepatide, longevity medicine, human enhancement, Dr Anant Vinjamoori, peptides, anti aging, healthspan, lifespan, metabolic health, obesity drugs, biotechnology, AI drug discovery, programmable biology, cell signaling, longevity biotech, future of healthcare, precision medicine.

We Will Green The Deserts | Augustus Doricko, Rainmaker

We can control the weather. But almost nobody is ready for that.Augustus Doricko, founder of Rainmaker, is building precipitation and weather modification technology that flies drones directly into clouds to increase rainfall at scale - and one day terraform entire planets.Hosted by Mgoes → https://x.com/m_goes_distanceBrought to you by SuperHuman Fund → https://superhuman.fund/---0:00 - Climate Change - Mitigate vs Adapt07:50 - Water Scarcity Tech & Cloud Seeding14:52 - Modelling Complex Systems17:32 - Towards Atmospheric Engineering24:52 - Technical Bottlenecks32:29 - China’s $300M Weather Program35:36 - State Bans & Political Backlash40:43 - Public Fear vs Sexy Tech47:17 - Falcon 1 → Terraforming51:10 - Greening Australia55:00 - AI in Weather Modeling---The Accelerate Bio Podcast explores the future of humanity in the age of Artificial Intelligence. Subscribe for deep-dive conversations with founders, scientists, and investors shaping energy, AI, biotechnology, and human progress.---This episode discusses cloud seeding, weather modification, Rainmaker, Augustus Doricko, water scarcity, Great Salt Lake, drought solutions, climate adaptation, geoengineering, precipitation technology, silver iodide, weather drones, atmospheric science, China cloud seeding, water security, terraforming deserts, AI weather modeling, hydroelectric power, water policy, deeptech climate.

Why Billionaires Still Haven’t Solved Aging | Aubrey de Grey

Aging is fully reversible. But neither billionaires nor AI will get us there.Dr Aubrey de Grey, founder of modern longevity, explains why aging must be treated as a solvable damage problem, why modern longevity efforts are structurally misallocated, why a single breakthrough in mice could trigger a global war on aging, and what happens to society once people expect to live indefinitely.Hosted by Mgoes → https://x.com/m_goes_distanceDonate to Aubrey's LEV Foundation → https://www.levf.org/---0:00 - Longevity Field 20 Years On08:58 - Are Billionaires Getting It Wrong?17:13 - Bryan Johnson vs Peter Thiel23:42 - ChatGPT Moment for Longevity28:52 - Biological Age vs Lifespan34:44 - Influencers Will Save Us39:36 - AI x Science Breakthroughs48:14 - Sam Altman on Aging53:39 - Genesis Mission56:45 - Systems Will Collapse1:08:55 - GLP-1s & Human Enhancement---The Accelerate Bio Podcast explores the future of human potential in the age of Artificial Intelligence. Subscribe for deep-dive conversations with founders, scientists, and investors shaping energy, AI, biotechnology, and human progress.Brought to you by BiohackerDAO.---Keywords: Aubrey de Grey, longevity escape velocity, anti aging, aging research, lifespan extension, rejuvenation biotechnology, SENS Research Foundation, senolytics, healthspan vs lifespan, biological age, longevity science, AI in biotech, AI longevity, billionaires longevity, Calico, Altos Labs, Jeff Bezos longevity, Google Calico, Silicon Valley longevity, war on aging, human life extension

America’s Future Runs on Longevity Biotech, Not AI | Omri Amirav-Drory, NFX

Longevity biotech is America’s next trillion-dollar bet. In this exclusive interview, NFX General Partner Omri Amirav-Drory explains why solving aging, not AI, is the real deeptech revolution.From radically extending human lifespan to reversing fertility decline, Omri lays out the ABCD plan for aging, why 160 years is the next milestone, and how TechBio - computation meets biology - will transform healthcare, biotech, and the economy.Despite biotech’s brutal crash, he argues now is the best time to invest and reveals the breakthroughs in AI and synthetic biology that could unlock new anti-aging technologies and human superpowers.Hosted by Mgoes: https://x.com/m_goes_distance---00:00:00 – Intro00:03:30 – Longevity as America’s Next Deeptech Frontier00:07:07 – Aging Population & The Fertility Crisis00:10:34 – The ABCD Plan For Lifespan Extension00:14:28 – How Far Away Are We From Living To 160?00:25:19 – TechBio: Computation, AI, Biology Combined00:33:30 – Will AI Solve All Problems in Biology?00:39:10 – America First, Evolution, and Vaccine Skepticism00:56:05 – Biotech Boom And Bust, Is It A Good Time To Invest?01:07:13 – Will Synbio Give Us Superpowers?---The Accelerate Bio Podcast explores the future of human potential in the age of Artificial Intelligence.Subscribe for weekly deep-dive interviews, to stay ahead of the curve and navigate this new era.We feature news, breakthroughs, and conversations with founders, investors, and visionaries shaping science, biotechnology, human enhancement, big data, AI, health tech, longevity, and more.---Brought to you by BiohackerDAO - A community dedicated to exploring and funding frontier technologies in human enhancement.